During the past decade, Montefiore Medical Center Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Montefiore Medical Center Oncology" are "Cytomegalovirus Infection" (1 trials) and "Squamous Cell Carcinoma of the Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Montefiore Medical Center Oncology" in a lesser frequency.

Most popular intervention types in "Montefiore Medical Center Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Brincidofovir" (1 trials), "Cetuximab" (1 trials), "EMD 1201081" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montefiore Medical Center Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Montefiore Medical Center Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Montefiore Medical Center Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Montefiore Medical Center Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".